Eco R1 Capital, LLC Apellis Pharmaceuticals, Inc. Transaction History
Eco R1 Capital, LLC
- $1.16 Billion
- Q2 2025
A detailed history of Eco R1 Capital, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 11,895,808 shares of APLS stock, worth $284 Million. This represents 17.74% of its overall portfolio holdings.
Number of Shares
11,895,808
Previous 11,895,808
-0.0%
Holding current value
$284 Million
Previous $260 Million
20.85%
% of portfolio
17.74%
Previous 20.45%
Shares
12 transactions
Others Institutions Holding APLS
# of Institutions
295Shares Held
132MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$292 Million3.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$243 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$233 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$215 Million0.03% of portfolio
-
Deep Track Capital, LP Greenwich, CT7MShares$167 Million4.3% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.63B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...